SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-044043
Filing Date
2024-04-12
Accepted
2024-04-12 16:14:00
Documents
8
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A scph-pre14a-2024_-_proxy.htm PRE 14A 943926
2 GRAPHIC img224713226_0.jpg GRAPHIC 13834
3 GRAPHIC img224713226_1.jpg GRAPHIC 18936
4 GRAPHIC img224713226_2.jpg GRAPHIC 18936
5 GRAPHIC img224713226_3.jpg GRAPHIC 184679
6 GRAPHIC img224713226_4.jpg GRAPHIC 33401
7 GRAPHIC img224713226_5.jpg GRAPHIC 718401
8 GRAPHIC img224713226_6.jpg GRAPHIC 178693
  Complete submission text file 0000950170-24-044043.txt   2551635
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38293 | Film No.: 24841609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)